Spatial TranscriptomicsRecent development in transcriptomics technologies (detection of RNA) enable quantification of RNA content of tissues and single cells. Especially spatial transcriptomics technologies that detect both transcripts and their spatial location have become available for researchers. The major breakthroughs in the field of spatial transcriptomics have been the spatial resolution (< 1 micrometer) and the possibilities to simultaneously detect all transcripts (genome wide). The major advantages of high-resolution spatial transcriptomics methods compared to single cell or single nuclei transcriptomics are the ability to investigate all cells including rare cells in a single tissue section while maintaining information on the cellular environment and neighboring cells. Especially in the field of neuroscience where the complexity and molecular diversity of the brain form challenges that make it extremely difficult to generate detailed and complete maps of protein expression using ‘bulk’ or single nuclei transcriptomics. Stereo-seq data on the human protein atlasThe brain resource now contains spatial transcriptomics data of the human ‘healthy’ cerebral cortex (frontal cortex, n=7)), pons (including locus coeruleus, n=8), cerebellum (n=3), hippocampus (n=3) and spinal cord (n=3). We now applied an adaptive binning approach to identify tissue niches based on unsupervised clustering. In many cases these niches contain specific neuronal subtypes, but also synaptic fields or passing axons contain transcripts drive tissue segmentation. Based on known anatomy and gene expression signatures niches were annotated resulting in 47 niches over 5 brain regions including gray matter (n=28) and white matter (n=5), vascular enriched (n=5), glia dominated (n=5), ventricle wall (n=1), choroid plexus (n=1) and meninges enriched (n=2) niches. Current limitation and challenges and future perspectivesThe field of spatial transcriptomics is relatively new and with the latest developments we now in theory can perform single cell spatial transcriptomics analysis. Spatial transcriptomics analysis of brain samples: The major technical challenges in molecular neuroscience have a biological origin. The brain has 1) many cell-types and cell states, 2) cell-types have different sizes and morphologies, 3) cell-types have different levels of overall transcriptional activity, and 4) the difference between sub-types or cell states often is a small fraction of total transcriptome. To create a molecular map of the brain at single cell resolutions we need to 1)capture all cell-types and cell-states in a large enough numbers to generate the necessary statistical power to compare between cell-types or cell-states, 2) create strategies to compare between cell-types with different morphologies and total transcript content, and 3) create sensitive assays to capture the minor but biological relevant differences between sub-types and cell states. The HPA approach to map the molecular and cellular landscape of the brain: In the field of high-resolution transcriptomics (resolution < single cell) several methods have been developed to group individual counts to single cells. Many of the currently used methods are imaged based and use a nuclear staining to define the cell-center and use a radius approach to link detected transcripts to these cells. This approach works for many tissues especially if the cells in these tissues have similar (round) shapes and overall total number of transcripts. For the analysis of brain, these methods are not well suited and have difficulty capturing cells with low number of transcripts (e.g. microglia, vascular cells) especially if these are near neurons that have high number of transcripts. In the Human Protein atlas project, we therefore use co-expression to link individual spots to a cell-types creating a cell-type mask. In the current version we demonstrate how this can be used to identify protein coding transcripts elevated in one of the five major cell-types and how to impute the possible location of transcripts in the cerebral cortex. Protein expression data: For each tissue niche all protein coding transcripts were pooled and counts per million (CPM) was determined and normalized using Trimmed Mean of M-values (TMM) normalization into normalized counts per million (nCPM). These values provide a quantitative measure for protien expression within tissue niches. In addition we applied our classification strategy to determin niche enriched (single niche), niche group enriched(set of niches) and niche enhanced. High resolution spatial transcriptomics approaches capture all transcripts including nuclear and cytoplasmic transcripts that are distributed throughout the neuronal and non-neuronal cells. As a result niche or layer specific neuronal markers difuse into other layers and whitematter due to the axonal and synaptic distribution of transcripts. We therefor lowered the enrichement factor to 2.25x for a transcript to be enriched. Future perspective: The data presented in the current version is based tissue niches that are microenvironments containing a mix of cell types, passing axons and synapses. This is not yet at a single cell type resolution. In previous version of the human protein atlas, we explored methods to assign transcript counts to the main cell types in the tissue based on single nuclei transcriptomics data. The absence of rare cell types from single cell datasets (especially pons and spinal cord) and difference in transcript distribution between nucleus and other cellular compartments complicate data integration, but also highlight the complementarity of these approaches. Relevant links and publications Ståhl PL et al., Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. (2016) Chen A et al., Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell. (2022) Liu L et al., Spatiotemporal omics for biology and medicine. Cell. (2024) van den Bosch AMR et al., Microglial states associate with lesion dynamics in multiple sclerosis. Cell Rep. (2026) |